News from NIAID-Supported Institutions

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases

NIAID News Twitter   NIAID Facebook   NIAID News Twitter   LinkedIn Icon
Visit us on the Web

Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:

Know Your Enemy: Combating Whooping Cough Requires Informed Vaccine Booster Schedules   
January 19, 2015—University of Michigan

Rare Mutations Do Not Explain “Missing Heritability” in Asthma 
January 16, 2015—University of Chicago

"Universal Flu Vaccine" May Be Closer Than We Think, Says Mac Researcher 
January 15, 2015—McMaster University

Tumor Suppressor Protein Helps Immune System Stay Balanced 
January 15, 2015—St. Jude Children’s Research Hospital

Long-Acting Drug Effectively Prevents HIV-Like Infection in Monkeys 
January 15, 2015—The Rockefeller University

Vaccine-Induced CD4 T Cells Lead to Adverse Effect in a Mouse Model of Infection 
January 15, 2015—Beth Israel Deaconess Medical Center

Contract Research Organization WCCT Global Announced Collaboration Agreement with the NIAID for Influenza Challenge Research   
January 15, 2015—WCCT Global

Human Mode of Responding to HIV Vaccine Is Conserved From Monkeys 
January 15, 2015—Duke Medicine

3D Systems Partners with National Institutes of Health (NIH) to Advance Medical Innovations Through 3D Printing   
January 15, 2015—3D Systems

Possible Treatments Identified for Highly Contagious Stomach Virus   
January 13, 2015—Washington University School of Medicine in St. Louis
 
Study Links Common Human Protein to Adverse Parasitic Worm Infections 
January 8, 2015—University of California, Riverside

The Best Offense Against Bacteria is a Good Defense 
January 7, 2015—The Ohio State University

New Approach May Lead to Inhalable Vaccines for Influenza, Pneumonia 
January 7, 2015—University of North Carolina at Chapel Hill

Newly Discovered Antibiotic Kills Pathogens Without Resistance 
January 7, 2015—Northeastern University

Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen   
Jan. 6, 2015—Johnson & Johnson

Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial for the Ebola Vaccine Regimen of MVA-BN® Filo and Janssen’s AdVac® Technology 
January 6, 2015—Bavarian Nordic

Nearly Half-Million Dollar NIH Grant Awarded to Study Widespread Virus Affecting Infants 
January 6, 2015—Ohio University Heritage College of Osteopathic Medicine

Cold Virus Replicates Better at Cooler Temperatures 
January 5, 2015—Yale University

Soligenix Announces Positive Preliminary Nonclinical Results in Macrophage Activation Syndrome 
January 5, 2015—Soligenix, Inc.
 
Fat Isn’t All Bad: Skin Adipocytes Help Protect Against Infections 
January 5, 2015—University of California, San Diego School of Medicine

HIV Vaccines Should Avoid Viral Target Cells, Primate Model Study Suggests 
January 2, 2015—Emory University

Purdue Research Suggests Approach to Treat Virus Causing Respiratory Illness, Possible Paralysis in Children 
January 1, 2015—Purdue University
 

These news releases were issued by organizations supported by NIAID. To receive NIAID-issued news releases, update your subscription preferences by selecting “News Releases.”

If you would like to see your NIAID-supported research featured here, contact us at niaidnews@niaid.nih.gov.

 Bookmark and Share